TIAA FSB’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $83.7K | Hold |
17,592
| – | – | ﹤0.01% | 564 |
|
|
2023
Q1 | $100K | Hold |
17,592
| – | – | ﹤0.01% | 558 |
|
|
2022
Q4 | $178K | Hold |
17,592
| – | – | ﹤0.01% | 547 |
|
|
2022
Q3 | $394K | Hold |
17,592
| – | – | ﹤0.01% | 429 |
|
|
2022
Q2 | $436K | Hold |
17,592
| – | – | ﹤0.01% | 430 |
|
|
2022
Q1 | $682K | Hold |
17,592
| – | – | ﹤0.01% | 328 |
|
|
2021
Q4 | $1.03M | Hold |
17,592
| – | – | ﹤0.01% | 305 |
|
|
2021
Q3 | $1.04M | Hold |
17,592
| – | – | ﹤0.01% | 303 |
|
|
2021
Q2 | $1.53M | Hold |
17,592
| – | – | 0.01% | 286 |
|
|
2021
Q1 | $1.45M | Hold |
17,592
| – | – | 0.01% | 279 |
|
|
2020
Q4 | $1.6M | Sell |
17,592
-2,500
| -12% | -$227K | 0.01% | 265 |
|
|
2020
Q3 | $803K | Hold |
20,092
| – | – | ﹤0.01% | 253 |
|
|
2020
Q2 | $689K | Hold |
20,092
| – | – | ﹤0.01% | 255 |
|
|
2020
Q1 | $446K | Hold |
20,092
| – | – | ﹤0.01% | 250 |
|
|
2019
Q4 | $393K | Buy |
+20,092
| New | +$393K | ﹤0.01% | 281 |
|